Halozyme Therapeutics HALO
NASDAQ HALO
$109.23 +2.29 (+2.14%)
As of: Oct 2, 2026 · 2:00 PM EDT

Halozyme Therapeutics (HALO) Shares Outstanding (2010 - 2026)

Updated

Halozyme Therapeutics (HALO) recorded Shares Outstanding of 117.27 million in Q2 2026, down 3.4% from 121.34 million a year earlier and down 0.7% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Shares Outstanding (2010 - 2026) Analysis & Trends

For FY2025, Halozyme Therapeutics reported Shares Outstanding of 119.84 million, down 5.5% from FY2024.

  • Annual Shares Outstanding has declined for four straight years, with a five-year compound annual growth rate of -2.5% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding came in at 126.83 million in FY2024 (-3.9%), 131.93 million in FY2023 (-3.6%), 136.84 million in FY2022 (-2.7%) and 140.65 million in FY2021 (+3.3%).
  • Quarterly Shares Outstanding has ranged from 117.22 million in Q3 2025 to 142.02 million in Q3 2021 over the past five years.
  • On a year-over-year basis, Shares Outstanding has declined for 18 consecutive quarters, with an average decline of 4.5% over the last eight quarters.
  • Peak year-over-year performance for Shares Outstanding in the last five years was growth of 4.0% in Q3 2021, against a decline of 7.6% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at 118.14 million (Q1 2026), 119.84 million (Q4 2025) and 117.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.70 Mn
10 Halozyme Therapeutics 12.59 Bn 11.20 Bn 401.83 Mn 117.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.27 Mn
Mar 31, 2026 118.14 Mn
Dec 31, 2025 119.84 Mn
Sep 30, 2025 117.22 Mn
Jun 30, 2025 121.34 Mn
Mar 31, 2025 123.22 Mn
Dec 31, 2024 126.83 Mn
Sep 30, 2024 126.85 Mn
Jun 30, 2024 127.12 Mn
Mar 31, 2024 126.94 Mn
Dec 31, 2023 131.93 Mn
Sep 30, 2023 131.97 Mn
Jun 30, 2023 131.73 Mn
Mar 31, 2023 135.03 Mn
Dec 31, 2022 136.84 Mn
Sep 30, 2022 136.53 Mn
Jun 30, 2022 137.94 Mn
Mar 31, 2022 137.66 Mn
Dec 31, 2021 140.65 Mn
Sep 30, 2021 142.02 Mn
API Access

Halozyme Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=HALO&period=max&api_key=YOUR_API_KEY